ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.69903C>A (p.Phe23301Leu)

dbSNP: rs372799151
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000040548 SCV000064239 uncertain significance not specified 2014-03-06 criteria provided, single submitter clinical testing
GeneDx RCV000040548 SCV000237476 likely benign not specified 2017-11-30 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV001080058 SCV000555612 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-31 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000725637 SCV000701056 uncertain significance not provided 2017-03-09 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000725637 SCV001146475 benign not provided 2019-06-17 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001170571 SCV001333159 benign Cardiomyopathy 2018-02-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV002326749 SCV002627819 likely benign Cardiovascular phenotype 2019-05-03 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000725637 SCV003800503 likely benign not provided 2022-09-20 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000725637 SCV003825600 uncertain significance not provided 2023-11-14 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003904971 SCV004723268 likely benign TTN-related condition 2022-09-08 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.